against Pittsburgh-Corning, Fibreboard, Celotex, Carey-Canada, and ACL.
PHASE I
Phase I utilized the same procedures approved in Jenkins v. Raymark Industries, Inc. supra, to resolve all common issues. The issues were whether each asbestos containing insulation product manufactured by each defendant, settling and non-settling, was defective and unreasonably dangerous, the adequacy of warnings, the state of the art defense and the fiber type defense. The question of punitive damages in the entire case of the 2,298 class representatives was also submitted for jury determination.
PHASE II
Phase II required a jury finding for each of nineteen worksites during certain time periods regarding which asbestos containing insulation products were used, which crafts were sufficiently exposed to asbestos fibers from those products for such exposure to be a producing cause of an asbestos-related injury or disease and an apportionment of causation among defendants, settling and non-settling.
In other words, the exposure questions to be submitted would be specific as to time, place, craft, and amounts of exposure.
PHASE III
Phase III is the damage issue. The 2,298 class members were divided into five disease categories based on the plaintiffs injury claims. The Court selected a random sample from each disease category as follows:
SAMPLE SIZE DISEASE CATEGORY POPULATION
The damage case of each trial sample class member randomly drawn was then submitted to a jury. Each plaintiff whose damage case was submitted to the jury is to be awarded his individual verdict and the average verdict for each disease category will constitute the damage award for each non-sample class member.
Plaintiffs have agreed to the procedure, thereby waiving their rights to individual damage determinations.
THE TRIAL
Phase I began with jury selection on February 6, 1990 and the verdict was returned March 29, 1990. The Court then granted the parties’ request for additional preparation time between Phase I and Phases II and III. Two juries were selected on July 3, 1990. The juries sat together for the first five trial days which were devoted to general medical testimony. The juries were then divided and began hearing testimony on groups of plaintiffs and returning damage verdicts. The last verdict for the 160 individual damages cases was received October 5, 1990.
In all, the trial consumed 133 days of trial time and produced 25,348 pages of transcript prepared as daily copy. The docket sheet in the Clerk’s office is 529 pages long. The Court has entered 373 signed Orders.
Prior to trial 1,885 sets of interrogatories were answered by the parties and 2,354 depositions were taken, with an additional 800 being taken during trial. Independent medical examinations were conducted of 1,400 plaintiffs.
During the course of the trial, 271 expert witnesses and 292 fact witnesses testified, 6,176 exhibits were received in evidence constituting 577,000 pages of documents. Fifty-eight individual lawyers participated in the in-court presentation of this case which was presided over in varying degrees by four district judges and three magistrates.
If all that is accomplished by this is the closing of 169 cases, then it was not worth the effort and will not be repeated.
PHASE II — STIPULATION
Phase II of the trial was designed to resolve the issue of the plaintiffs’ exposure